
pmid: 31512925
Aim: Creation of a single indicator of access to medicines. Methods: Data collection was performed with individuals who obtained their medication from either public and/or private pharmacies. A Likert scale was used to measure the importance and satisfaction in relation to various access dimensions. Results: A total of 580 individuals were interviewed. Overall, participants attributed very similar importance scores to the dimensions of access to medicines. The results of the mean score of each dimension showed a statistically significant difference according to the type of pharmacy that the participant visited. Conclusion: This developed indicator will enable a review of access to medicines, making comparisons possible as well as improving decision making about public policies in the field of Pharmaceutical Services.
Adult, Male, Pharmacies, Insurance, Health, Adolescent, Data Collection, 610, Middle Aged, Health Services Accessibility, Young Adult, Pharmacy and materia medica, 615, Pharmaceutical Services, Humans, Female, Facilities and Services Utilization
Adult, Male, Pharmacies, Insurance, Health, Adolescent, Data Collection, 610, Middle Aged, Health Services Accessibility, Young Adult, Pharmacy and materia medica, 615, Pharmaceutical Services, Humans, Female, Facilities and Services Utilization
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 12 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
